About Gensco Pharma

Gensco® Leadership Team

Gensco® is a specialty pharmaceutical manufacturer specializing in development and commercialization of prescription topically-applied transdermal products. Our capabilities allow us to quickly launch products into significant niche markets. Our Leadership Team oversees organizational goals, strategic planning development, and overall decision making.

Medical Advisory Board

We currently have relationships with key medical advisors including:

 

James R. Andrews, MD, Orthopedic Surgeon
James R. Andrews, MD

Orthopedic Surgeon Andrews Sports Medicine and Orthopedic Medicine.
view biography

Gary E. Meyerson, MD
Gary E. Myerson, MD

Rheumatologist Arthritis & Rheumatology Georgia, P.C.
view biography

Alesia Wagner, DO, FACOFP
Alesia Wagner, DO, FACOFP

Associate Professor, Primary Care Touro University College of Osteopathic Medicine
view biography

Marc Alan Brenner, DPM
Marc Alan Brenner, DPM

Podiatrist The Institute for Diabetic Foot Research
view biography

Executive Team

Our executive leadership team is comprised of proven leaders with a diverse background but the singular goal of helping us achieve our strategic vision.

 

Carlos Alfaras, President & CEO
Carlos Alfaras

President & CEO
view biography

Urbano Zamora

SVP, Operations & Manufacturing

Tom Scarlata, RPh, Senior VP, Commercialization
Tom Scarlata, RPh

SVP, Commercialization

Frank Aguilar, VP, National Accounts
Frank Aguilar

VP, National Accounts

Robert L. Wilbur, Pharm.D., CPh, Executive Director, Medical Affairs
Robert L. Wilbur, Pharm.D., CPh

Executive Director, Medical Affairs
view biography

David Andry, Senior Director National Accounts
David A. Andry

Senior Director National Accounts

Lewis Archibeck | Sr. Sales Executive
Lewis Archibeck

Sr. Sales Executive

Lisa Capote, Esq., General Counsel
Lisa Capote, Esq

General Counsel

MISSION STATEMENT

Gensco® Pharma is committed to Better Science for Health.

Our resources are focused on innovative research, the development of superior quality medications and unique delivery systems. We are an evidence-based solutions company that is progressively developing products utilizing new technologies that deliver outcomes to reduce the effects caused by disease or pathology.

GENSCO® TRENDING

Looking To The Future

A single dose topical colchinium for acute gout flares.
LidoDose Logo
A single dose topical anesthetic for injections and vaccines.
See all news